CVE-2023-41088
The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow an attacker with access to the network, where clients have access to the DexGate server, could capture traffic.
Does this matter?
Lower severity and a low EPSS score (0.24%). Track it; it rarely justifies an emergency change on its own.
Description
The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow an attacker with access to the network, where clients have access to the DexGate server, could capture traffic. The attacker can later us the information within it to access the application.
- CVSS 3.1
- 6.5 MEDIUMCVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N
- EPSS
- 0.24% probability · 15th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-319
- Affected
- dexma/dexgate
- Source
- ics-cert@hq.dhs.gov
References
- https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02Third Party Advisory, US Government Resource
- https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.